Vanguard Group Inc Royalty Pharma PLC Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Vanguard Group Inc holds 37,585,123 shares of RPRX stock, worth $948 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
37,585,123
Previous 38,022,381
1.15%
Holding current value
$948 Million
Previous $1 Billion
6.05%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding RPRX
# of Institutions
413Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.04 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY23MShares$581 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$407 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$305 Million1.32% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.9MShares$300 Million0.62% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...